European Patent, Blood Flow Regulation, LivaNova, 15th Apr
Summary
The European Patent Office published application EP4132605A1 for LivaNova Deutschland GmbH, covering a method and system for regulating blood flow in extracorporeal circulation. The application was published April 15, 2026, with inventors Penka and Schubert listed, and classified under A61M 1/36 and related A61M 60/ categories. The patent designates all contracting states including DE, FR, GB, NL, IT, ES, and 25 other European jurisdictions.
About this source
GovPing monitors EPO Patent Bulletin - Medical Devices (A61M) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 32 changes logged to date.
What changed
The EPO published European patent application EP4132605A1 for LivaNova Deutschland GmbH, covering methods and systems for regulating blood flow in extracorporeal circulation. The application is classified under A61M 1/36 and multiple A61M 60/ subclasses, indicating a cardiac or circulatory support device. Inventors are listed as Penka and Schubert. The publication date is April 15, 2026.
Medical device manufacturers and competitors in the extracorporeal circulation or cardiac support space should review the application's claims to assess potential overlap with existing product lines or development pipelines. While the patent is still pending (A1 indicates publication of application, not yet grant), publication begins the 18-month window before substantive examination and creates prior art dates for competing innovations.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
REGULATING BLOOD FLOW IN EXTRACORPOREAL CIRCULATION
Publication EP4132605A1 Kind: A1 Apr 15, 2026
Applicants
LivaNova Deutschland GmbH
Inventors
PENKA, Ottmar, SCHUBERT, Friedemann
IPC Classifications
A61M 1/36 20060101AFI20260306BHEP A61M 60/109 20210101ALI20260306BHEP A61M 60/232 20210101ALI20260306BHEP A61M 60/38 20210101ALI20260306BHEP A61M 60/523 20210101ALI20260306BHEP A61M 60/531 20210101ALI20260306BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.